BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30515170)

  • 1. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
    Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
    Front Immunol; 2018; 9():2695. PubMed ID: 30515170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
    Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
    Front Immunol; 2018; 9():2078. PubMed ID: 30283440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
    Lork M; Staal J; Beyaert R
    Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular architecture and regulation of BCL10-MALT1 filaments.
    Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
    Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
    Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
    Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A
    De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
    Front Immunol; 2018; 9():2366. PubMed ID: 30429846
    [No Abstract]   [Full Text] [Related]  

  • 11. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
    Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.
    Wang Z; Hutcherson SM; Yang C; Jattani RP; Tritapoe JM; Yang YK; Pomerantz JL
    J Biol Chem; 2019 Oct; 294(40):14648-14660. PubMed ID: 31391255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells.
    Kutzner K; Woods S; Karayel O; Gehring T; Yin H; Flatley A; Graß C; Wimberger N; Tofaute MJ; Seeholzer T; Feederle R; Mann M; Krappmann D
    Sci Signal; 2022 Mar; 15(723):eabk3083. PubMed ID: 35230873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
    Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
    J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.